Stocksigma LogoStocksigma Logo

Vivo Bio Tech Board to Consider Q2 Results on 11th Nov'26

Vivo Bio Tech Limited has scheduled a Board of Directors meeting on 11th Nov'26 to consider and approve the unaudited standalone and consolidated financial

Vivo Bio Tech Board to Consider Q2 Results on 11th Nov'26

Vivo Bio Tech Ltd 路 Intimation 路 11 Nov 2026, 5:30 am

Vivo Bio Tech Board to Consider Q2 Results on 11th Nov'26 Vivo Bio Tech Limited has scheduled a Board of Directors meeting on 11th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th Sep'26. Consequently, the trading window for all designated persons, directors, promoters, and connected entities remains closed until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Vivo Bio Tech Ltd

All Vivo Bio Tech Ltd announcements